Vireo Growth Expands Colorado Presence with PharmaCann Acquisition
Claim 70% Off TipRanks This Holiday Season
- Unlock hedge-fund level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Vireo Growth ( (TSE:VREO) ) is now available.
On December 16, 2025, Vireo Growth Inc. and its wholly owned subsidiary Vireo Health, Inc. entered into a definitive Asset Purchase Agreement to acquire certain retail assets and properties of PharmaCann Inc. in Colorado, including 17 cannabis dispensaries. The all-share transaction, valued at about $49 million in subordinate voting shares plus the assumption of certain liabilities and subject to customary post-closing adjustments and resale restrictions, will increase Vireo’s Colorado retail footprint to 41 active dispensaries and deepen its position in the state’s adult-use cannabis market. A Vireo subsidiary also signed a Management Services Agreement to operate the dispensaries prior to closing, which is expected in the first half of 2026, with completion contingent on regulatory approvals and other closing conditions; the deal aligns with Vireo’s strategy of pursuing accretive M&A to optimize its Colorado operating footprint and strengthen its competitive retail position.
More about Vireo Growth
Vireo Growth Inc., founded in 2014 as a medical cannabis pioneer, operates a disciplined, execution-focused cannabis platform with a strong local market focus supported by a national portfolio. The company concentrates on adult-use and medical cannabis retail and related operations, deploying capital and industry talent to build scale in key U.S. markets while emphasizing long-term value for customers, employees, shareholders, partners and the communities it serves.
YTD Price Performance: -1.23%
Average Trading Volume: 65,368
Technical Sentiment Signal: Buy
Current Market Cap: C$851.7M
See more data about VREO stock on TipRanks’ Stock Analysis page.
